» Articles » PMID: 22474448

Polymorphisms in HSD17B1: Early Onset and Increased Risk of Alzheimer's Disease in Women with Down Syndrome

Overview
Specialty Geriatrics
Date 2012 Apr 5
PMID 22474448
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background/Aims. Genetic variants that affect estrogen activity may influence the risk of Alzheimer's disease (AD). In women with Down syndrome, we examined the relation of polymorphisms in hydroxysteroid-17beta-dehydrogenase (HSD17B1) to age at onset and risk of AD. HSD17B1 encodes the enzyme 17β-hydroxysteroid dehydrogenase (HSD1), which catalyzes the conversion of estrone to estradiol. Methods. Two hundred and thirty-eight women with DS, nondemented at baseline, 31-78 years of age, were followed at 14-18-month intervals for 4.5 years. Women were genotyped for 5 haplotype-tagging single-nucleotide polymorphisms (SNPs) in the HSD17B1 gene region, and their association with incident AD was examined. Results. Age at onset was earlier, and risk of AD was elevated from two- to threefold among women homozygous for the minor allele at 3 SNPs in intron 4 (rs676387), exon 6 (rs605059), and exon 4 in COASY (rs598126). Carriers of the haplotype TCC, based on the risk alleles for these three SNPs, had an almost twofold increased risk of developing AD (hazard ratio = 1.8, 95% CI, 1.1-3.1). Conclusion. These findings support experimental and clinical studies of the neuroprotective role of estrogen.

Citing Articles

Inherited Disorders of Coenzyme A Biosynthesis: Models, Mechanisms, and Treatments.

Cavestro C, Diodato D, Tiranti V, Di Meo I Int J Mol Sci. 2023; 24(6).

PMID: 36983025 PMC: 10054636. DOI: 10.3390/ijms24065951.


Investigation of Mitochondrial Related Variants in a Cerebral Small Vessel Disease Cohort.

Dunn P, Harvey N, Maksemous N, Smith R, Sutherland H, Haupt L Mol Neurobiol. 2022; 59(9):5366-5378.

PMID: 35699875 PMC: 9395495. DOI: 10.1007/s12035-022-02914-3.


Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome.

Iulita M, Garzon Chavez D, Christensen M, Tamayo N, Plana-Ripoll O, Rasmussen S JAMA Netw Open. 2022; 5(5):e2212910.

PMID: 35604690 PMC: 9127560. DOI: 10.1001/jamanetworkopen.2022.12910.


The Pathophysiological Role of CoA.

Czumaj A, Szrok-Jurga S, Hebanowska A, Turyn J, Swierczynski J, Sledzinski T Int J Mol Sci. 2020; 21(23).

PMID: 33260564 PMC: 7731229. DOI: 10.3390/ijms21239057.


Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer's disease.

Kobayashi N, Shinagawa S, Niimura H, Kida H, Nagata T, Tagai K Sci Rep. 2020; 10(1):12217.

PMID: 32699290 PMC: 7376092. DOI: 10.1038/s41598-020-69248-9.


References
1.
Judd H, Shamonki I, Frumar A, Lagasse L . Origin of serum estradiol in postmenopausal women. Obstet Gynecol. 1982; 59(6):680-6. View

2.
Garcia-Segura L, Azcoitia I, Doncarlos L . Neuroprotection by estradiol. Prog Neurobiol. 2000; 63(1):29-60. DOI: 10.1016/s0301-0082(00)00025-3. View

3.
Hughes T, Borenstein A, Schofield E, Wu Y, Larson E . Association between late-life body mass index and dementia: The Kame Project. Neurology. 2009; 72(20):1741-6. PMC: 2683740. DOI: 10.1212/WNL.0b013e3181a60a58. View

4.
Wu A, Seow A, Arakawa K, van den Berg D, Lee H, Yu M . HSD17B1 and CYP17 polymorphisms and breast cancer risk among Chinese women in Singapore. Int J Cancer. 2003; 104(4):450-7. DOI: 10.1002/ijc.10957. View

5.
Drake E, Henderson V, Stanczyk F, McCleary C, BROWN W, Smith C . Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology. 2000; 54(3):599-603. DOI: 10.1212/wnl.54.3.599. View